Previous 10 | Next 10 |
Athira Pharma ATHA -65% as lead asset fails in Alzheimer’s trial. WISeKey International WKEY -43% on reports that it expects revenue growth in semiconductors IoT segment despite shortages in manufacturing. Micro Focus International (MFGP) -18%. Tabula Rasa HealthCar...
Gainers: Convey Health Solutions Holdings (CNVY) +139%. Valneva (VALN) +86%. Green Giant (GGE) +78%. CEA Industries (CEAD) +76%. Clovis Oncology (CLVS) +71%. Tabula Rasa HealthCare (TRHC) +34%. Revlon (REV) +34%. Innate Pharma (IPHA) +33%. Sorrento Therapeutics (SRNE) +28%. MacroGenics (MGNX)...
Tabula Rasa HealthCare Agrees to Sell its PrescribeWellness Business to Transaction Data Systems PR Newswire The Companies also Agree to a Strategic Multi-Year Partnership MOORESTOWN, N.J. , June 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare...
4th Annual CareVention HealthCare Summit Attracts Record Interest PR Newswire Nearly 40 PACE executives expected to attend this year's conference more than doubling 2021 Summit attendance MOORESTOWN, N.J. , June 7, 2022 /PRNewswire/ -- Tabula Ra...
The problem I've been moaning about for years persists. Namely, the more Tabula Rasa HealthCare sells, the more it loses. If growing sales won't lead to profits, what will? In addition, the capital structure has deteriorated significantly since I last reviewed Tabula Rasa. The level o...
Tabula Rasa HealthCare, Inc. (TRHC) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Kevin Dill – Corporate Counsel Calvin Knowlton – Founder, Chairman and Chief Executive Officer Orsula Knowlton – Founder, President and Chief Marketing Officer...
Tabula Rasa HealthCare press release (NASDAQ:TRHC): Q1 GAAP EPS of -$0.85 beats by $0.11. Revenue of $67.1M (+14.2% Y/Y) misses by $17.78M. For further details see: Tabula Rasa HealthCare GAAP EPS of -$0.85 beats by $0.11, revenue of $67.1M misses by $17.78M
Tabula Rasa HealthCare Reports First Quarter 2022 Results PR Newswire First quarter 2022 revenue of $67.1 million from continuing operations includes CareVention HealthCare revenue of $66.3 million , up 19% vs. a year ago Planned sales of PrescribeWel...
Tabula Rasa HealthCare Schedules First Quarter 2022 Earnings Conference Call PR Newswire MOORESTOWN, N.J. , April 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its first qu...
Tabula Rasa HealthCare (NASDAQ:TRHC) rose 1.5% after a report that the company is said be exploring options for some of its businesses. TRHC is exploring options for its PrescribeWellness and medication therapy management units, according to an Axios Pro report. Talks are taking place wi...
News, Short Squeeze, Breakout and More Instantly...
Tabula Rasa HealthCare Inc. Company Name:
TRHC Stock Symbol:
NASDAQ Market:
Tabula Rasa HealthCare Inc. Website:
Tabula Rasa HealthCare Inc. (TRHC) is expected to report $-0.12 for Q3 2023
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) is the focus of IBN's latest stock spotlight. The company's shares have moved 0.05% on the day to $10.41. Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention...
Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners PR Newswire MOORESTOWN, N.J. , Oct. 31, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing pe...